Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)
眼睛生长、正视眼和感光器间视黄醇结合蛋白 (IRBP)
基本信息
- 批准号:9769038
- 负责人:
- 金额:$ 43.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectBindingBiochemical PathwayBuffersCessation of lifeChemicalsCorneaDefectDevelopmentDevelopmental BiologyDiseaseDropsDrosophila eyeDrug TargetingEnvironmental Risk FactorEyeEye diseasesFDA approvedFatty AcidsGenesGenetic PolymorphismGenetic RiskGrantGrowthHealthHumanHuman GenomeKnock-outKnockout MiceKnowledgeLeadLearningLengthLightLight CellModelingMorphologyMusMutant Strains MiceMutationMyopiaNeurotoxinsOpticsOrgan SizeOther GeneticsOutcome MeasurePathologyPathway interactionsPatternPharmaceutical PreparationsPharmacotherapyPopulationProtein DeficiencyProteinsPupil light reflexRefractive ErrorsRegulator GenesRegulatory PathwayRetinaRetinal DegenerationRetinoidsRoleSignal TransductionSymptomsTestingTimeVertebrate PhotoreceptorsVisionWorkbasedifferential expressiondisabling symptomdrug efficacydrug testingefficacy testinggenetic linkage analysisgenetic pedigreegenome wide association studyhuman subjectinnovationinterstitial retinol-binding proteinouter plexiform layerpreventreduce symptomsresponsesmall moleculevisual cycle
项目摘要
SUMMARY
IRBP is expressed much earlier than needed for any putative role in the visual cycle. In the previous grant
cycle, we showed that IRBP is needed in early retina development, as without it we detected morphological
changes coincident with terminal differentiation of rods and cones, and precocious development of the outer
plexiform layer.
At the same time, we discovered excessive eye growth and elongation of the optical axis starting distinctly at
P7. This implies a role for IRBP in controlling eye growth even without vision-based signaling.
We now know that IRBP loss causes diverse and severe eye diseases including profound myopia and retinal
degeneration, and we recently discovered sluggish pupillary light reflexes (PLRs).
In recent human GWAS studies, IRBP polymorphisms are associated with refractive error and corneal
curvature. Previous linkage studies established that IRBP defects caused combined RP and severe myopia.
We view abnormalities of IRBP deficiency in the context of eye disease that affect normal determination of eye
size, based on strong and abundant previous and concurrent work in developmental biology of the Drosophila
eye and organ size fate. We test the same five principal pathways that regulate size determination in the IRBP
knockout eye.
We seek to understand posited hierarchical relationships among myopia, RD, and other abnormalities in IRBP
mutations. To do that we have constructed and validated a new conditional knockout (KO) mouse and a new
traditional KO. Here we use them to sort out the temporal, spatial, and mechanistic relationships that cause
these three major symptoms. Last, we test efficacy of drugs known to slow myopia or organ size, in the IRBP-/-
model asking if they are effective in reducing any or all IRBP deficiency symptoms.
总结
IRBP的表达早于视觉周期中任何假定作用所需的时间。在上一次赠款中,
周期,我们表明IRBP是需要在早期视网膜发育,因为没有它,我们检测形态
这些变化与视杆细胞和视锥细胞的终末分化以及外胚层的早熟发育相一致
网状层
与此同时,我们发现过度的眼睛生长和光轴的延长明显开始于
P7。这意味着IRBP在控制眼睛生长中的作用,即使没有基于视觉的信号。
我们现在知道,IRBP缺失会导致各种严重的眼部疾病,包括深度近视和视网膜病变。
退化,我们最近发现瞳孔对光反射(PLRs)迟缓。
在最近的人类GWAS研究中,IRBP多态性与屈光不正和角膜炎相关。
曲率先前的连锁研究确定IRBP缺陷导致RP和严重近视的组合。
我们认为IRBP缺乏症的异常在眼睛疾病的背景下,影响眼睛的正常决定,
大小,基于强大和丰富的先前和同时在果蝇发育生物学方面的工作
眼睛和器官大小的命运我们测试相同的五个主要途径,调节大小的决定,在IRBP
迷人的眼睛
我们试图了解近视,RD和IRBP中其他异常之间的假定层次关系
突变。为此,我们构建并验证了一种新的条件性敲除(KO)小鼠和一种新的
传统KO在这里,我们使用它们来整理时间,空间和机械关系,导致
这三大症状。最后,我们在IRBP-/-中测试了已知减缓近视或器官大小的药物的功效。
模型询问他们是否有效地减少任何或所有IRBP缺乏症症状。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY H BOATRIGHT其他文献
JEFFREY H BOATRIGHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY H BOATRIGHT', 18)}}的其他基金
Atypical opsins and the OIR model of retinopathy of prematurity
非典型视蛋白与早产儿视网膜病变的 OIR 模型
- 批准号:
10675898 - 财政年份:2023
- 资助金额:
$ 43.68万 - 项目类别:
A TrkB Activator for Treatment of Glaucoma
用于治疗青光眼的 TrkB 激活剂
- 批准号:
10261458 - 财政年份:2018
- 资助金额:
$ 43.68万 - 项目类别:
The RPE and Recovery of the Blood Retina Barrier
RPE 和血视网膜屏障的恢复
- 批准号:
10163852 - 财政年份:2018
- 资助金额:
$ 43.68万 - 项目类别:
A TrkB Activator for Treatment of Glaucoma
用于治疗青光眼的 TrkB 激活剂
- 批准号:
10475096 - 财政年份:2018
- 资助金额:
$ 43.68万 - 项目类别:
The RPE and Recovery of the Blood Retina Barrier
RPE 和血视网膜屏障的恢复
- 批准号:
10415948 - 财政年份:2018
- 资助金额:
$ 43.68万 - 项目类别:
A TrkB Activator for Treatment of Glaucoma
用于治疗青光眼的 TrkB 激活剂
- 批准号:
10039602 - 财政年份:2018
- 资助金额:
$ 43.68万 - 项目类别:
Bridging animal and human models of exercise-induced visual rehabilitation
连接运动引起的视觉康复的动物和人类模型
- 批准号:
8924254 - 财政年份:2015
- 资助金额:
$ 43.68万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 43.68万 - 项目类别:
Discovery Projects